VNUS Medical predicts 2007 launch for faster vein closer catheter:
This article was originally published in Clinica
VNUS Medical Technologies could be set to commercialise next year a faster version of its radiofrequency (RF) ablation catheter for closing diseased veins. So said the San Jose, California firm, after its first human trial of the new device, ClosureFAST, produced positive results. Over 30 patients were treated with the catheter under local anaesthetic at three European centres and all the treatments were successful at occluding the great saphenous vein, both acutely and at a three day post-procedure, the company reported. In addition, the catheter heated, shrunk and occluded the refluxing saphenous veins with RF ablation times of just three to five minutes, indicating that it could significantly speed up procedures, while providing patients the RF treatment benefit of rapid recovery with minimal or no discomfort.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.